Amundi acquired a new stake in shares of Nature’s Sunshine Products, Inc. (NASDAQ:NATR – Free Report) in the fourth quarter, Holdings Channel reports. The firm acquired 4,381 shares of the company’s stock, valued at approximately $63,000.
Other large investors have also added to or reduced their stakes in the company. Proficio Capital Partners LLC purchased a new position in Nature’s Sunshine Products during the fourth quarter valued at $200,000. Franklin Resources Inc. raised its stake in Nature’s Sunshine Products by 4.3% during the third quarter. Franklin Resources Inc. now owns 20,744 shares of the company’s stock valued at $270,000 after buying an additional 856 shares during the last quarter. Bailard Inc. purchased a new position in Nature’s Sunshine Products during the fourth quarter valued at $302,000. JPMorgan Chase & Co. raised its stake in Nature’s Sunshine Products by 24.3% during the third quarter. JPMorgan Chase & Co. now owns 34,633 shares of the company’s stock valued at $472,000 after buying an additional 6,769 shares during the last quarter. Finally, Barclays PLC raised its stake in Nature’s Sunshine Products by 51.8% during the third quarter. Barclays PLC now owns 35,602 shares of the company’s stock valued at $485,000 after buying an additional 12,152 shares during the last quarter. Hedge funds and other institutional investors own 79.40% of the company’s stock.
Nature’s Sunshine Products Trading Down 1.6 %
Shares of NASDAQ:NATR opened at $12.39 on Friday. The stock has a fifty day simple moving average of $14.19 and a two-hundred day simple moving average of $14.35. The stock has a market capitalization of $229.02 million, a price-to-earnings ratio of 14.08 and a beta of 0.91. Nature’s Sunshine Products, Inc. has a 12-month low of $10.81 and a 12-month high of $21.22.
Nature’s Sunshine Products Profile
Nature’s Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.
Featured Stories
- Five stocks we like better than Nature’s Sunshine Products
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
- Buy P&G Now, Before It Sets A New All-Time High
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- The Role Economic Reports Play in a Successful Investment Strategy
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
Want to see what other hedge funds are holding NATR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nature’s Sunshine Products, Inc. (NASDAQ:NATR – Free Report).
Receive News & Ratings for Nature's Sunshine Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nature's Sunshine Products and related companies with MarketBeat.com's FREE daily email newsletter.